SLCO1B1 rs4149056 polymorphism associated with statin-induced myopathy is differently distributed according to ethnicity in the Brazilian general population: Amerindians as a high risk ethnic group
Open Access
- 12 October 2011
- journal article
- research article
- Published by Springer Nature in BMC Medical Genetics
- Vol. 12 (1) , 136
Abstract
Recent studies reported the association between SLCO1B1 polymorphisms and the development of statin-induced myopathy. In the scenario of the Brazilian population, being one of the most heterogeneous in the world, the main aim here was to evaluate SLCO1B1 polymorphisms according to ethnic groups as an initial step for future pharmacogenetic studies.Keywords
This publication has 27 references indexed in Scilit:
- CYP2C19 and ABCB1gene polymorphisms are differently distributed according to ethnicity in the Brazilian general populationBMC Medical Genetics, 2011
- APOE polymorphism is associated with lipid profile, but not with arterial stiffness in the general populationLipids in Health and Disease, 2010
- The SLCO1B1*5Genetic Variant Is Associated With Statin-Induced Side EffectsJACC, 2009
- Prevalência e fatores de risco associados à doença arterial periférica no projeto corações do BrasilArquivos Brasileiros de Cardiologia, 2008
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide StudyNew England Journal of Medicine, 2008
- SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acidPharmacogenetics and Genomics, 2006
- Clinical Implications of Nonopioid Analgesia for Relief of Mild-to-Moderate Pain in Patients with or at Risk for Cardiovascular DiseaseThe American Journal of Cardiology, 2006
- Statin Safety: A Systematic ReviewThe American Journal of Cardiology, 2006
- An Assessment of Statin Safety by Muscle ExpertsThe American Journal of Cardiology, 2006
- Statins, Cardiovascular Disease, and Drug SafetyThe American Journal of Cardiology, 2006